Evergreen Theragnostics

Evergreen Theragnostics, founded in 2019, is a leading radiopharmaceutical contract development and manufacturing organization (CDMO) headquartered in the United States. Evergreen Theragnostics' team of expertise and proven track record in the commercialization of sinus-related radiopharmaceuticals, manufacturing process development, and regulatory affairs management makes it an ideal partner for meeting all of its customers’ radiopharmaceutical development, manufacturing, and commercialization needs.